Swine vesicular disease (SVD) is a highly contagious viral disease that causes vesicular disease in pigs. The importance of the disease is due to its indistinguishable clinical signs from those of foot-and-mouth disease, which prevents international trade of swine and related products. SVD-specific antibody detection via an enzyme-linked immunosorbent assay (ELISA) is the most versatile and commonly used method for SVD surveillance and export certification. Inactivated SVD virus is the commonly used antigen in SVD-related ELISA. A recombinant SVD virus-like particle (VLP) was generated by using a Bac-to-Bac baculovirus expression system. Results of SVD-VLP analyses from electron microscopy, western blotting, immunofluorescent assay, and mass spectrometry showed that the recombinant SVD-VLP morphologically resemble authentic SVD viruses. The SVD-VLP was evaluated as a replacement for inactivated whole SVD virus in competitive and isotype-specific ELISAs for the detection of antibodies against SVD virus. The recombinant SVD-VLP assay produced results similar to those from inactivated whole virus antigen ELISA. The VLP-based ELISA results were comparable to those from the virus neutralization test for antibody detection in pigs experimentally inoculated with SVD virus. Use of the recombinant SVD-VLP is a safe and valuable alternative to using SVD virus antigen in diagnostic assays.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583424 | PMC |
| http://dx.doi.org/10.4142/jvs.2017.18.S1.361 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Crimean-Congo hemorrhagic fever cases diagnosed during an outbreak of Sudan virus disease in Uganda, 2022-23.
PLoS Negl Trop Dis
October 2024
Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, United States of America.
Background: In September 2022, Uganda experienced an outbreak of Sudan virus disease (SVD), mainly in central Uganda. As a result of enhanced surveillance activities for Ebola disease, samples from several patients with suspected viral hemorrhagic fever (VHF) were sent to the VHF Program at Uganda Virus Research Institute (UVRI), Entebbe, Uganda, and identified with infections caused by other viral etiologies. Herein, we report the epidemiologic and laboratory findings of Crimean-Congo hemorrhagic fever (CCHF) cases that were detected during the SVD outbreak response.
View Article and Find Full Text PDFThe Role of Community Beliefs and Practices on the Spread of Ebola in Uganda, September 2022.
J Epidemiol Glob Health
December 2024
Uganda Public Health Fellowship Program, Kampala, Uganda.
Article Synopsis
- Uganda faced a Sudan Virus Disease outbreak starting September 2022, spreading to multiple districts and prompting a study on community beliefs that contributed to its spread.
- A qualitative study in February 2023 involved focus groups and interviews, revealing that local beliefs often attributed deaths to witchcraft or poisoning, leading patients to seek traditional healing before formal medical care.
- The analysis indicated that cultural practices, such as hiding patients and unsafe burial customs, facilitated transmission, suggesting that integrating traditional healers and religious leaders into public health strategies could enhance control measures.
Understanding the delay in identifying Sudan Virus Disease: gaps in integrated disease surveillance and response and community-based surveillance to detect viral hemorrhagic fever outbreaks in Uganda, September 2022.
BMC Infect Dis
July 2024
Division of Global Health Protection, Global Health Center, Centers for Disease Control and Prevention, Kampala, Uganda.
Article Synopsis
- Uganda's Integrated Disease Surveillance and Response (IDSR) system aims for early outbreak detection, but the Sudan virus outbreak in 2022 highlighted gaps in community and health facility reporting.* -
- A study evaluated surveillance capacities in public and private health facilities, revealing that 85% of surveyed private facilities failed to report to the national system, and many lacked trained staff.* -
- Identified gaps included weak community surveillance, poor engagement of private facilities, low awareness of Viral Hemorrhagic Fever, and insufficient funding and training for effective reporting.*
Delayed treatment of cynomolgus macaques with a FVM04/CA45 monoclonal antibody cocktail provides complete protection against lethal Sudan virus infection.
J Virol
August 2024
Special Pathogens program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Unlabelled: Sudan ebolavirus (SUDV) is a member of the genus (Family ) and has caused sporadic outbreaks of Ebola disease (EBOD), or more specifically Sudan virus disease (SVD), with high mortality rates in Africa. Current vaccines and therapies that have been developed for filoviruses are almost all specific for Ebola virus (EBOV; of the species ), and there is a current lack of therapeutics specific for SUDV. The recent SUDV outbreak in Uganda, which was distributed across multiple districts, including Kampala, a densely populated urban center, highlights the critical need for the development of novel SUDV-specific or pan-Ebola virus therapeutics.
View Article and Find Full Text PDFIndividual and household risk factors for Ebola disease among household contacts in Mubende and Kassanda districts, Uganda, 2022.
BMC Infect Dis
May 2024
Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Kampala, Uganda.
Background: In 2022, an Ebola disease outbreak caused by Sudan virus (SUDV) occurred in Uganda, primarily affecting Mubende and Kassanda districts. We determined risk factors for SUDV infection among household members (HHM) of cases.
Methods: We conducted a case-control and retrospective cohort study in January 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!